Literature DB >> 1722217

A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein.

R H Scofield1, W D Dickey, K W Jackson, J A James, J B Harley.   

Abstract

The Ro ribonucleoprotein is composed of hY RNA and a 60.7-kD peptide that is antigenic for autoantibodies produced by many patients with systemic lupus erythematosus or Sjögren's syndrome and mothers of newborns with complete congenital heart block. A major immunoreactive fragment (13 kD) of the 60-kD Ro is bound by 28 of 45 (62%) of the anti-Ro sera tested. Amino acid sequence analysis localizes this fragment to the carboxyl end of the 60-kD Ro peptide. All possible overlapping octapeptides of this 13-kD peptide of 60-kD Ro have been assessed for antigenicity. Sera that bind the 13-kD peptide fragment in immunoblot generally also bind the octapeptides of Ro spanning the sequence AIALREYRKKMDIPA (P less than 0.01). Inhibition studies with synthetic peptides and purified Ro have established specificity for reference serum antibody binding to an antigenic octapeptide, EYRKKMDI, from this region. The closely related sequence EYRKKLMD is found in the nucleocapsid protein of vesicular stomatitis virus and may portend an immunologic link to this or a related viral antigen. These results also demonstrate that despite fine specificity variation between human sera, there are recurring patterns of anti-Ro binding shared by some patients who have precipitating anti-Ro autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722217     DOI: 10.1007/BF00918804

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

1.  Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera.

Authors:  H H Guldner; H J Netter; C Szostecki; H J Lakomek; H Will
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

Review 2.  Molecular mimicry in HLA-B27-related arthritis.

Authors:  D T Yu; S Y Choo; T Schaack
Journal:  Ann Intern Med       Date:  1989-10-01       Impact factor: 25.391

Review 3.  The antigenic structure of proteins: a reappraisal.

Authors:  D C Benjamin; J A Berzofsky; I J East; F R Gurd; C Hannum; S J Leach; E Margoliash; J G Michael; A Miller; E M Prager
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

4.  Elucidation of discontinuous linear determinants in peptides.

Authors:  J R Appel; C Pinilla; H Niman; R Houghten
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

5.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Staphylococcal protease: a proteolytic enzyme specific for glutamoyl bonds.

Authors:  J Houmard; G R Drapeau
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

7.  Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome.

Authors:  J B Harley; M Reichlin; F C Arnett; E L Alexander; W B Bias; T T Provost
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

8.  Molecular mimicry. Yeast histone H3-induced experimental autoimmune uveitis.

Authors:  V K Singh; K Yamaki; L A Donoso; T Shinohara
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

9.  Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen.

Authors:  E Ben-Chetrit; B J Gandy; E M Tan; K F Sullivan
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

10.  Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients.

Authors:  M B Frank; R McArthur; J B Harley; A Fujisaku
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

View more
  9 in total

Review 1.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

2.  The ultrastructural localization of 60-kDa Ro protein and human cytoplasmic RNAs: association with novel electron-dense bodies.

Authors:  A D Farris; F Puvion-Dutilleul; E Puvion; J B Harley; L A Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

3.  Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.

Authors:  Renate Claus; Heiko Hickstein; Thomas Külz; Ute Lenschow; Doris Meiske; Andrea Kotitschke; Hans-Jürgen Thiesen; Peter Lorenz
Journal:  Rheumatol Int       Date:  2006-01-10       Impact factor: 2.631

Review 4.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

5.  Antibodies to EYRKK vesicular stomatitis virus-related peptide account only for a minority of anti-Ro60kD antibodies.

Authors:  J G Routsias; M Sakarellos-Daitsiotis; E Detsikas; A G Tzioufas; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

Review 6.  Use of synthetic peptides for the detection and quantification of autoantibodies.

Authors:  K B Elkon
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

7.  Immunogenetics of epitopes of the carboxyl terminus of the human 60-kD Ro autoantigen.

Authors:  R H Scofield; W D Dickey; K L Hardgrave; B R Neas; R M Horowitz; R A McArthur; A Fujisaku; M B Frank; J B Harley; A ] Fujisak A [corrected to Fujisaku
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

8.  Characterization of murine monoclonal antibodies against 60-kD Ro/SS-A and La/SS-B autoantigens.

Authors:  C H Veldhoven; G J Pruijn; J F Meilof; J P Thijssen; A W Van der Kemp; W J Van Venrooij; R J Smeenk
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

Review 9.  Therapy of systemic lupus erythematosus: a look into the future.

Authors:  Josef S Smolen
Journal:  Arthritis Res       Date:  2002-05-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.